The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.
Rachel Williams is a small business editor at Forbes Advisor with two decades of professional editing experience. Over the last five years, she has specialized in small business content, helping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results